Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 98.80

From 52W high−15.65%

Volume5.49M

Market capCNY 50.49B

P/E (TTM)23.1x

P/S (TTM)8.0x

Div yield1.20%

Key dataSep 18, 2026

Open

CNY 98.80

From 52W high

−15.65%

Volume

5.49M

Market cap

CNY 50.49B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

16.7x

P/E (TTM)

23.1x

RSI (14)

37.3

MomentumView details →

1D Return

−3.70%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

23.1x

EV/EBITDA

16.7x

EV/Sales

7.7x

P/S (TTM)

8.0x

P/B (TTM)

6.0x

ProfitabilityView details →

Gross Margin

96.31%

Net Margin

42.57%

EBITDA Margin

46.27%

ROE (TTM)

31.18%

ROA (TTM)

28.12%

Asset Turnover

0.69x

GrowthView details →

Revenue YoY

+44.95%

EPS YoY

+57.37%

FCF YoY

+78.85%

Revenue CAGR 3Y

+87.18%

EPS CAGR 3Y

+155.91%

EBITDA YoY

—

MomentumView details →

1D Return

−3.70%

YTD Return

—

1Y Return

—

RSI (14)

37.3

vs 50D SMA

−11.83%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

5.25x

Quick Ratio

5.17x

Div Yield

1.20%

Div Rate

CNY 1.20

Div Growth 1Y

+50.00%

EarningsView details →

EPS (Actual)

CNY 2.01

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

5.67B

Net Income (TTM)

2.41B

Op. CF (TTM)

2.48B

Next earningsOct 26, 2026 →

Latest newsMore news →

Ailisi announced a cash dividend of 6.00 yuan per 10 shares, totaling 270 million yuan, for the first half of 2026.32d ago

Allist Pharmaceuticals forecast first-half 2026 revenue of 3.31 billion yuan and net profit of 1.54 billion yuan, up 39.44% and 46.49% year-on-year respectively, driven by furmonertinib sales.33d ago

Similar companies

Amicogen, Inc.092040.KQ Pharmaron Beijing Co., Ltd.03759.HK GeneOne Life Science, Inc.011000.KS Asymchem Laboratories (Tianjin) Co., Ltd.06821.HK Encell Co. Ltd.456070.KQ RemeGen Co., Ltd.09995.HK Find similar companies →

Latest newsMore news →

Ailisi announced a cash dividend of 6.00 yuan per 10 shares, totaling 270 million yuan, for the first half of 2026.32d ago Allist Pharmaceuticals forecast first-half 2026 revenue of 3.31 billion yuan and net profit of 1.54 billion yuan, up 39.44% and 46.49% year-on-year respectively, driven by furmonertinib sales.33d ago